Brief Behavioral Activation Treatment for Postpartum Depression
(SUMMIT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
SUMMIT's (Scaling Up Maternal Mental health care by Increasing access to Treatment) overarching goal is to examine the scalability and patient-centered provision of brief, evidence-based psychological treatments for perinatal depression and anxiety (N=1226). Specifically, and through a multi-site, randomized, pragmatic trial, the trial examines whether a brief, behavioral activation (BA) treatment delivered via telemedicine is as effective as the same treatment delivered in person; and whether BA delivered by non-mental health providers (e.g., nurses), with appropriate training is as effective as when delivered by specialist providers (psychiatrists, psychologists and social workers) in reducing perinatal depressive and anxiety symptoms. The study will be conducted in Toronto, NorthShore University HealthSystem in Evanston and surrounding areas including Chicago, and North Carolina. The trial will also identify relevant underlying implementation processes and determine whether, and to what extent, these strategies work differentially for certain women over others.
Who Is on the Research Team?
Daisy R Singla, PhD
Principal Investigator
Sinai Health System
Are You a Good Fit for This Trial?
The SUMMIT trial is for pregnant women up to 36 weeks or those who are 4-30 weeks postpartum, experiencing depression with an EPDS score of at least 10. Participants must be over 18 and speak English or Spanish. It excludes those with severe fetal issues, recent infant death, active suicidal thoughts, psychosis, recent psychotropic medication changes, ongoing psychotherapy, substance abuse issues, or non-English/Spanish speakers.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a brief, manualized behavioral activation treatment delivered either in-person or via telemedicine by specialists or trained non-specialists
Follow-up
Participants are monitored for depressive and anxiety symptoms using standardized scales
Child Mental Health Development
Child mental development is assessed using the Bayley Mental Developmental Scale IV and Home Observation Measurement Evaluation
What Are the Treatments Tested in This Trial?
Interventions
- Brief Behavioral Activation Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mount Sinai Hospital, Canada
Lead Sponsor
Endeavor Health
Collaborator
University of North Carolina, Chapel Hill
Collaborator
Sunnybrook Health Sciences Centre
Collaborator
Harvard Medical School (HMS and HSDM)
Collaborator
Women's College Hospital
Collaborator
Unity Health Toronto
Collaborator
Patient-Centered Outcomes Research Institute
Collaborator
NorthShore University HealthSystem
Collaborator
University of Colorado, Boulder
Collaborator